{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:46Z","timestamp":1761807886206},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1093\/brain\/awu153","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T12:41:36Z","timestamp":1406119296000},"page":"2115-2116","source":"Crossref","is-referenced-by-count":5,"title":["Glycine receptor antibodies in PERM: a new channelopathy"],"prefix":"10.1093","volume":"137","author":[{"given":"Pilar","family":"Martinez-Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc H.","family":"de Baets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,7,21]]},"reference":[{"key":"key\n\t\t\t\t20170405085545_awu153-B1","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170405085545_awu153-B2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-510X(70)90154-1","article-title":"The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man","volume":"10","author":"Cutler","year":"1970","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170405085545_awu153-B3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.20653","article-title":"Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome","volume":"34","author":"Espay","year":"2006","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170405085545_awu153-B4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2012.06824.x","article-title":"Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?","volume":"1274","author":"Gomez","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20170405085545_awu153-B5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405085545_awu153-B6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930701619490","article-title":"Autoantibody-mediated disorders of the central nervous system","volume":"41","author":"Irani","year":"2008","journal-title":"Autoimmunity"},{"key":"key\n\t\t\t\t20170405085545_awu153-B7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2353\/ajpath.2007.060676","article-title":"Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis","volume":"170","author":"Martinez-Martinez","year":"2007","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170405085545_awu153-B8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fgene.2013.00181","article-title":"Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders","volume":"4","author":"Martinez-Martinez","year":"2013","journal-title":"Front Genet"},{"key":"key\n\t\t\t\t20170405085545_awu153-B9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.10279","article-title":"Stiff man syndrome and related conditions","volume":"17","author":"Meinck","year":"2002","journal-title":"Movement disorders: official Move Disord"},{"key":"key\n\t\t\t\t20170405085545_awu153-B10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/08916930903518081","article-title":"Development of novel therapies for MG: studies in animal models","volume":"43","author":"Souroujon","year":"2010","journal-title":"Autoimmunity"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/137\/8\/2115\/11140652\/awu153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T22:47:46Z","timestamp":1503442066000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awu153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,21]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,7,21]]},"published-print":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awu153","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,21]]}}}